Evidence map›Paper›PMID 41575661›Full record

ArticleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2026

Consensus document between oncology and primary care for the follow-up of cancer survivors.

Rosario Vidal-Tocino, Rafael Manuel Micó Pérez, María Hernández Miguel, Yolanda Ginés, Raúl Hernanz, Lourdes Martinez-Berganza Asensio, Ruth Vera García, Fátima Santolaya Sardinero, Elena Brozos Vázquez, Jacinto Batíz Cantera and 1 more

Abstract readConsensus Statement
In one paragraph

Article in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Rosario Vidal-TocinoDepartment of Medical Oncology, Hospital Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain. mrvidal@saludcastillayleon.es.ORCID http://orcid.org/0000-0002-0588-2001
Rafael Manuel Micó PérezDepartment of Health Xátiva-Ontinyent, Centro Fontanars dels Alforins, Valencia, Spain.
María Hernández MiguelDepartment of Radiotherapic Oncology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain.
Yolanda GinésHealth Centre Isla de Oza Primary Healthcare, Madrid, Spain.
Raúl HernanzDepartment of Radiotherapic Oncology, Hospital Universitario Ramón y Cajal, and GenesisCare, Madrid, Spain.
Lourdes Martinez-Berganza AsensioHealth Centre Ensanche de Vallecas, Madrid, Spain.
Ruth Vera GarcíaDepartment of Medical Oncology, Hospital Universitario de Navarra, Instituto de Investigación de Navarra (IdiSNA), Salamanca, Spain.
Fátima Santolaya SardineroHealth Centre Ciudad San Pablo, Coslada, Madrid, Spain.
Elena Brozos VázquezDepartment of Medical Oncology, Complejo Hospitalario Universitario de Santiago de Compostela, A Coruña, Spain.
Jacinto Batíz CanteraHospital San Juan de Dios, Santurce, Vizcaya, Spain.
Cruz Bartolomé-MorenoHealth Centre Parque Goya, Zaragoza, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The exponential growth of cancer survivors represents a major healthcare challenge, with more than 23 million people in Europe and 2.2 million in Spain requiring long-term specialized follow-up. Five-year survival has reached 60% in our country, creating a growing population of long-term survivors who need comprehensive care beyond the stage of active oncological treatment. This consensus document between oncology and primary care professionals establishes a care framework based on shared management for the follow-up of cancer survivors. The proposed model is based on the principles of continuity and ongoing communication, equity in access, and efficiency in resource use, recognizing that the needs of these patients go beyond purely medical aspects to encompass physical, psychological, social, and functional dimensions. This proposal defines a dynamic risk stratification that enables the identification of high-risk patients, who will continue to receive preferential hospital follow-up, and low-risk patients, whose care can be led by primary care with the support of other specialists. Specific roles are established for each level of care, along with bidirectional communication pathways and multidisciplinary coordination tools that include shared medical records, agreed protocols, and rapid referral channels.

Indexed as

AftercareCancer SurvivorsMedical OncologyNeoplasmsPrimary Health CareContinuity of Patient CareFollow-Up StudiesHumansCancer survivorsOncologyPrimary careRisk stratificationShared monitoring

Identifiers

PMID41575661
PMCPMC13282341

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.